Board

BRF Sadia INAUGURATES NEW PLANT IN SAUDI ARABIA

Retrieved on: 
Wednesday, July 6, 2022 - 8:43am

DAMMAM, Saudi Arabia, July 6, 2022 /PRNewswire/ --BRF Sadia, one of the largest food companies in the world, has inaugurated its new plant 'Al Joody' in Dammam, Saudi Arabia.

Key Points: 
  • DAMMAM, Saudi Arabia, July 6, 2022 /PRNewswire/ --BRF Sadia, one of the largest food companies in the world, has inaugurated its new plant 'Al Joody' in Dammam, Saudi Arabia.
  • Present at the ceremony were Marcos Molina, BRF Sadia Chairman of the Board; Lorival Luz, BRF Sadia Global CEO; and Igor Marti, BRF Sadia Vice President for the Halal Market, as well as representatives from the ministries of investment and industry and mineral resources of the Kingdom of Saudi Arabia, the Eastern region municipality and Modon.
  • BRF Sadia's history in Saudi Arabia began in the mid-1970s, when Sadia was the first company to introduce and democratize frozen chicken products in the Middle East.
  • In addition to Saudi Arabia, BRF Sadia is present in all main countries within the Halal region.

BRF Sadia INAUGURATES NEW PLANT IN SAUDI ARABIA

Retrieved on: 
Wednesday, July 6, 2022 - 8:27am

DAMMAM, Saudi Arabia, July 6, 2022 /PRNewswire/ --BRF Sadia, one of the largest food companies in the world, has inaugurated its new plant 'Al Joody' in Dammam, Saudi Arabia.

Key Points: 
  • DAMMAM, Saudi Arabia, July 6, 2022 /PRNewswire/ --BRF Sadia, one of the largest food companies in the world, has inaugurated its new plant 'Al Joody' in Dammam, Saudi Arabia.
  • Present at the ceremony were Marcos Molina, BRF Sadia Chairman of the Board; Lorival Luz, BRF Sadia Global CEO; and Igor Marti, BRF Sadia Vice President for the Halal Market, as well as representatives from the ministries of investment and industry and mineral resources of the Kingdom of Saudi Arabia, the Eastern region municipality and Modon.
  • BRF Sadia's history in Saudi Arabia began in the mid-1970s, when Sadia was the first company to introduce and democratize frozen chicken products in the Middle East.
  • In addition to Saudi Arabia, BRF Sadia is present in all main countries within the Halal region.

Independent Director Andrey Sharonov Elected Chairman of PhosAgro’s Board of Directors

Retrieved on: 
Wednesday, July 6, 2022 - 8:01am

Moscow The Board of Directors of PJSC PhosAgro (Moscow Exchange, LSE: PHOR), one of the worlds leading vertically integrated phosphate-based fertilizer producers, elected the independent director Andrey Sharonov as its Chairman at its first meeting following the Annual General Meeting of Shareholders.

Key Points: 
  • Moscow The Board of Directors of PJSC PhosAgro (Moscow Exchange, LSE: PHOR), one of the worlds leading vertically integrated phosphate-based fertilizer producers, elected the independent director Andrey Sharonov as its Chairman at its first meeting following the Annual General Meeting of Shareholders.
  • Alexander Sharabaiko was elected Deputy Chairman of the Board of Directors.
  • The independent director Viktor Cherepov was elected Chairman of the Audit Committee; Ivan Rodionov was elected Chairman of the Remuneration and Human Resources Committee; and Alexander Sharabaiko was elected Chairman of the Strategy and Sustainable Development Committee.
  • The meeting also approved a preliminary work plan for the Board of Directors for the period until 30 June 2023.

DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.

Key Points: 
  • We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.
  • We supply the most comprehensive integrated diagnostic solutions to support an appropriate use of antibiotics (antimicrobial stewardship), said Alexandre Mrieux, bioMrieux Chairman and CEO.
  • Our role within the joint venture is to develop and commercialize diagnostic tests, including Companion Diagnostics, which deliver rapid, reliable and actionable results.
  • bioMrieux has over 55 years of diagnostics expertise with more than 75% of its research and development budget focused on antimicrobial resistance.

TERRAOIL SWISS AG: Terraoil Announces Date for Extraordinary Shareholders’ Meeting

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

Extraordinary Shareholders Meeting to be held on July 21, 2022

Key Points: 
  • Extraordinary Shareholders Meeting to be held on July 21, 2022
    Steinhausen, Switzerland, July 6, 2022 - Terraoil Swiss AG, an energy company with a strong focus on the Mediterranean is pleased to announce that it has set the date for an extraordinary Shareholders Meeting to be held by proxy on July 21, 2022.
  • 27 of the Covid 19 Ordinance 3, the Board of Directors has decided to hold the extraordinary Shareholders' Meeting without the personal participation of shareholders.
  • This media release serves informational purposes and constitutes neither an offer to sell nor a solicitation or an advertisement to buy any shares of Terraoil Swiss AG in any jurisdiction.
  • The forward-looking statements contained in this media release are based on the views and assumptions of Terraoil Swiss AG as of this date and Terraoil Swiss AG does not assume any obligation to update or revise this media release.

DENTSPLY SIRONA INC. (NASDAQ: XRAY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Retrieved on: 
Wednesday, July 6, 2022 - 6:30am

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Ohio and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • Dentsply produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • As (former) executives of Dentsply, Defendants Donald M. Casey, Jr. (Casey) and Jorge Gomez (Gomez) were eligible for significant cash- and stock-based incentive compensation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange

Retrieved on: 
Wednesday, July 6, 2022 - 6:45am

BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the TASE).

Key Points: 
  • BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange (the TASE).
  • Under applicable Israeli law, the delisting of BiomXs shares of common stock from trading on the TASE is expected to become effective in three months, on October 6, 2022.
  • BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases.
  • For example, when BiomX discusses its expectations regarding the timing and benefits of delisting from TASE and expectation of continued listing on the NYSE American, BiomX is making forward-looking statements.

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Retrieved on: 
Wednesday, July 6, 2022 - 6:50am

The aspiration is to succeed in the fight against AMR, which is a major public health threat.

Key Points: 
  • The aspiration is to succeed in the fight against AMR, which is a major public health threat.
  • The rise of antibiotic-resistant infections also called antimicrobial resistance, or AMR is indeed a looming global crisis, said Michel Pairet, Head of Boehringer Ingelheims Innovation Unit and Member of the Board of Managing Directors.
  • We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.
  • bioMrieux has over 55 years of diagnostics expertise with more than 75 percent of its research and development budget focused on antimicrobial resistance.

DENTSPLY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY

Retrieved on: 
Wednesday, July 6, 2022 - 3:50am

This action is pending in the United States District Court for the Southern District of Ohio.

Key Points: 
  • This action is pending in the United States District Court for the Southern District of Ohio.
  • Dentsply investors should visit us at https://claimsfiler.com/cases/nasdaq-xray-1/ or call toll-free (844) 367-9658.
  • Dentsply and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements.

Fujitsu Develops New Technology for Accurately Estimating Postures of the Human Body from Point Cloud Data Using Millimeter-wave Sensor

Retrieved on: 
Wednesday, July 6, 2022 - 2:38am

TOKYO, July 6, 2022 - (JCN Newswire) - Fujitsu has successfully developed a new technology to accurately estimate postures of the human body from coarse-grained point cloud data obtained with a conventional millimeter-wave sensor.

Key Points: 
  • TOKYO, July 6, 2022 - (JCN Newswire) - Fujitsu has successfully developed a new technology to accurately estimate postures of the human body from coarse-grained point cloud data obtained with a conventional millimeter-wave sensor.
  • To address this issue, Fujitsu has developed a technology that enables expansion from coarse-grained point cloud data to fine-grained point cloud data necessary for an accurate posture estimation by fusing time series information of point cloud data in a series of movements of the human body.
  • Fujitsu has developed a new technology that enables a detailed analysis of human behavior using a common 79 GHz millimeter-wave sensor compliant with the Radio Law of Japan.
  • (3) Postures of the human body can be expressed as time-series point cloud data as even a general millimeter-wave sensor with a coarse granularity of point cloud data that can be acquired by radio wave irradiation at one time can achieve highly accurate estimation.